请使用支持JavaScript的浏览器!
主营:基因芯片、二代测序NGS测序仪及相关测序试剂盒
banner
当前位置: 首页 > 产品中心 > Clinical Research Products > Illumina/TruSight Rapid Capture (1 index, 8 samples, 8 enrichments)/FC-140-1101/1 Ea

Illumina/TruSight Rapid Capture (1 index, 8 samples, 8 enrichments)/FC-140-1101/1 Ea

Illumina/TruSight Rapid Capture (1 index, 8 samples, 8 enrichments)/FC-140-1101/1 Ea
  • Illumina/TruSight Rapid Capture (1 index, 8 samples, 8 enrichments)/FC-140-1101/1 Ea
商品介绍

ProductHighlights:

Targetinggenespreviouslylinkedtoapredispositiontowardscancer.

  • DevelopedincollaborationwithProfessorNazneenRahmanandteamattheInstituteofCancerResearch(ICR),London
  • Targets94genesand284SNPsassociatedwithapredispositiontowardscancer

TruSightCancerincludesgenesassociatedwithbothcommon(e.g.,breast,colorectal)andrarecancers.Inaddition,thesetincludes284SNPsfoundtocorrelatewithcancerthroughgenome-wideassociationstudies(GWAS).Contentselectionwasbasedonexpertcurationofthescientificliteratureandotherhigh-qualityresources.

TheTruSightCancersequencingpanelprovidescustomoligostargetingidentifiedregionsofinterest.Sufficientproductissuppliedforfourenrichmentreactions.TruSightCanceriscompatIBLewithTruSightRapidCapture.

TruSightCancerSampleDatasets

6humanreferencesampleswerepreparedusingtheTruSightCancersequencingpanel.TheselibrariesweresequencedontheMiniSeqSystemusingahighoutputkitata2x100bpreadlengthconfigurationwithdualindexing.Thetotalyieldwas5.2Gbwith95.8%ofbasesatoraboveQ30.

BrowsethedatainBaseSpaceSequenceHub:
  • ViewRun
  • ViewProject

*NotethataccesstothisdatarequiresaBaseSpaceSequenceHublogin.
RegisterforBaseSpaceSequenceHub

Specifications:

AssayTime1.5days
InputQuantity50ng
SystemCompatibilityMiSeq,NextSeq550,MiSeqDxinResearchMode,MiniSeq,NextSeq500
SpecializedSampleTypesLowInput
TechnologySequencing
SpeciesCategoryHuman
VariantClassGermlineVariants
CancerTypePan-Cancer
MethodTargetedDNASequencing
品牌介绍

Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go

While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination

Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics



蚂蚁淘(ebiomall)作为一家生命科学领域的垂直电商平台,公司专注生物医学科研用品的全球导购和品牌推广,为海内外厂方与代理经销商搭建跨境贸易系统和交流平台。产品齐全,200+分类,1000+品牌,500万+产品信息。100%正品,专业售后,到货快,在线下单, 简单轻松,节省科学家宝贵的科研时间。为您竭诚服务!

【订购】蚂蚁淘生物科技  联系方式:4000-520-616

更多产品,更多优惠!请联系我们!

苏州蚂蚁淘生物科技有限公司

免费热线:4000-520-616

官网:https://www.ebiomall.cn/



Illumina多种常见的分子生物学试剂

核糖体RNA去除试剂,DNA / RNA提取试剂盒,PCR试剂等

特色分子生物学试剂

使用Ribo-Zero Plus进行Illumina链式总RNA制备

从多种物种(包括人类,小鼠,大鼠,细菌和流行病学样本)快速制备文库,用于研究编码和非编码转录组。

无Illumina适配器封闭剂

一种酶解解决方案,可阻止来自库池的免费适配器,从而降低索引跳变率和未对齐的可能性。

Infinium FFPE QC和DNA恢复试剂盒

评估样品质量并修复降解的FFPE DNA样品,以用于基于Infinium阵列的测定。

rRNA和球蛋白mRNA消耗选择指南

Illumina解决方案为RNA-Seq文库的制备树立了核糖体RNA和球蛋白mRNA去除的标准。

流行的Illumina分子生物学试剂

Illumina Ribo-Zero Plus rRNA消耗试剂盒:该试剂盒可去除人,小鼠,大鼠和细菌样品中的核糖体RNA。

用于Illumina文库制备,索引和衔接子的AmpliSeq:查找设计用于AmpliSeq用于Illumina扩增子文库制备产品的试剂,包括用于cDNA合成和文库归一化的溶液。

Illumina标签DNA TDE1酶和缓冲液试剂盒:这些成分经常用于ATAC-Seq实验中以分析染色质的可及性。

HT1杂交缓冲液:该试剂用于在测序前稀释PhiX对照文库和变性文库。 

所有试剂盒和试剂:查看Illumina产品的完整列表。按系统,方法,种类和其他类别过滤以缩小列表。 

震中试剂

Illumina于2011年收购了Epicenter Biotechnologies,后者是核酸样品提取试剂和专门的分子生物学酶的领先供应商。收购的关键组成部分是使用Nextera技术进行快速,简单的下一代测序(NGS)文库制备。

Illumina继续提供Nextera技术(现称为Illumina DNA Prep)以及 用于RNA测序的Ribo-Zero rRNA去除解决方案。

但是,Epicentre最初开发的某些分子生物学试剂,包括下面列出的试剂,现在可以从Lucigen获得。

cDNA合成试剂:查找第一链cDNA合成试剂盒,包括Epicenter MessageBOOSTER和MMLV试剂盒,用于下游应用,例如实时PCR和终点RT-PCR。

PCR试剂盒和试剂:可使用多种PCR酶和试剂盒,从标准PCR到高保真,富含GC的长模板PCR。查找最初来自Epicentre的FailSafe和MasterAmp产品。

核酸纯化和提取试剂盒:从多种样品类型和种类中分离出DNA和RNA,用于多种下游应用,包括NGS和阵列。

所有Lucigen Epicenter产品:查看Lucigen现在可提供的前Epicenter产品的完整列表。


自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
在线客服
客服电话

4000-520-616

0512-67156496